The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Seroxat 30 mg film-coated tablets



LTT Pharma LimitedPPA1562/030/004

Main Information

Trade NameSeroxat 30 mg film-coated tablets
Active SubstancesParoxetine hydrochloride hemihydrate
Dosage FormFilm-coated tablet
Licence HolderLTT Pharma Limited
Licence NumberPPA1562/030/004

Group Information

ATC CodeN06AB Selective serotonin reuptake inhibitors
N06AB05 paroxetine

Status

License statusWithdrawn
Withdrawn Date14/04/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0076-033-003
Interchangeable List DocumentPDF of Interchangeable List
« Back